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Abstract
Background: Research turnover in the HIV field is rapid, and as a result, maintaining high-quality, up-to-date, and
relevant systematic reviews is a challenge. One approach is to frequently update published reviews.
Methods: We evaluated the methods and relevance of all HIV systematic reviews and protocols published in the
Cochrane Library over a 16-year period (2000–2016) to determine the need to update published reviews or complete
of reviews in progress.
Results: Of 148 published reviews and protocols, 129 (87%) were identified as not for updating or progression to
publication, mostly due to research questions which were either entirely outdated or addressed questions in an
outdated manner (N = 89; 60%); this was anticipated for older reviews, but was found also to be the case for recent
publications. Some research questions were also inadequately conceptualized, particularly when complex pragmatic
trials or behavioral interventions were included.
Conclusions: We suggest that authors clearly characterize interventions and synthesis approaches in their review
protocols. In research fields, such as HIV, where questions change frequently, systematic reviews and protocols should
be regularly re-evaluated to ensure relevance to current questions. This process of re-evaluation should be incorporated
into the methods of living systematic reviews.
Background
The HIV field has high research outputs, and the cycle
of questions, trials, and guideline modification is rapid.
This raises the question of how to keep HIV systematic
reviews up to date, relevant, and derived from the high-
est methodological standards [1, 2]. One approach is to
regularly update reviews to incorporate new findings;
and indeed, some questions endure and should be up-
dated; and for others however, the review question may
have been answered, changed substantially, or become
irrelevant, and blindly updating such reviews can result
in wasted effort and resources. To provide insight into
how review questions change over time, we formally ap-
praised the relevance, methods, and need to update a
suite of HIV systematic reviews and protocols published
in the Cochrane Library between 2000 and 2016.
Methods
Between 1 May 2016 and 30 May 2018, we critically ap-
praised all published Cochrane HIV reviews and proto-
cols based on the Cochrane Updating Classification
System [3, 4]. The Updating Classification System acts
as a guide to readers to assess whether a review is up to
date, needs updating, or might need updating in the fu-
ture [3, 4]. We modified the tool for assessing protocols.
Reviews and protocols were appraised by evaluating: (a)
the currency and priority of the review question
(through discussion with experts in the field and explor-
ing the literature), (b) the methods, by using an abbrevi-
ated version of the MECIR standards [2], and (c)
whether there were new studies to be included in the re-
view, or whether another high-quality review had already
been published on the topic outside of Cochrane. Based
on the outcome of this assessment, we determined
whether reviews should be updated, and whether
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protocols should continue to full reviews. We catego-
rized them as follows: (1) continue with review update
or allow protocol to progress to full review and (2) not
for update or protocol progression due to (a) methodo-
logical concerns, (b) outdated research question, or (c)
review already up to date. At least two people read and
appraised each review independently, and the classifica-
tion was agreed in team meetings chaired by experi-
enced systematic review authors. The tool is available in
the Additional file 1.
Results
We identified and appraised 109 Cochrane HIV reviews
and 39 HIV protocols (148 articles in total), published
on the Cochrane Database of Systematic Reviews be-
tween 2000 and 2016. Review and protocol topics in-
cluded questions about HIV treatment interventions
(63%), HIV prevention interventions (32%), health sys-
tem interventions (2%), and interventions to improve
HIV diagnosis (3%). The majority of reviews (N = 98;
66%) were published between 2010 and 2016, with a
smaller proportion published between 2000 and 2009
(N = 50; 34%). We concluded that 19 (13%) of all reviews
and protocols were eligible for an update or progression
to full review, and the remaining 129 (87%) were
assessed as “not for updating or progression”.
Of the 109 published systematic reviews, 95 were
assessed as “not for updating” (87%). Of these, 62% had
outdated research questions (Fig. 1) where the intervention
was superseded by a superior intervention or by another
more up-to-date review, or where questions were already
answered, and there was little to no ongoing research in the
topic area. For example, a review of the “Effectiveness of
first-line tenofovir, emtricitabine and efavirenz for patients
with HIV” would not require updating as this question has
been answered. Another example is the use of HSV-2 sup-
pressive therapy for HIV prevention: this is no longer con-
sidered an option for HIV prevention; although there may
be some additional studies for inclusion, updating such a
review would be of little value to consumers or policy
makers. We discontinued 11 reviews due to methodological
errors (37%): this was the result of inadequately conceptual-
ized research questions (the population, interventions,
comparison, or outcomes were not sufficiently character-
ized or relevant). Sometimes, this led to “empty” reviews
(with no included studies after searches were conducted).
Another methodological problem was review questions
which were not unique to HIV populations, for example,
reviews evaluating drug effects in HIV subpopulations with
no clear rationale for why these agents would have different
outcomes in HIV-positive people.
Thirty-four of 39 protocols were stopped from pro-
gressing to full reviews (87%) (Fig. 1). The two main rea-
sons for discontinuation also included outdated research
questions. This included protocols where the topic was
no longer relevant to policy makers or consumers, or
where an important HIV research area was evaluated
but the protocol review question did not reflect current
Fig. 1 Outcomes of review and protocol appraisals
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practices or thinking. The remaining protocols were dis-
continued due to methodological limitations, as a result
of inadequately conceptualized research questions. Spe-
cifically, protocols encompassed a very broad set of
treatment strategies that were difficult to combine in
one review, or authors did not consider how to mean-
ingfully combine complex HIV interventions. This was
common in protocols which included behavioral HIV
prevention interventions and pragmatic implementation
trials. Thirty protocols were published more than 2 years
previously (interquartile range 3–9 years).
Discussion
This appraisal of Cochrane systematic reviews and pro-
tocols demonstrates that topics in the HIV field become
outdated quickly, and this was by far the commonest
reason for discontinuation of both reviews and proto-
cols, including those from more recent years. In
addition, changes in reporting standards over time re-
sulted in outdated methodology. Protocols which pro-
gressed slowly became irrelevant before completion, and
inadequately conceptualized research questions resulted
in disorganized or empty reviews which, at times, did
not address issues specifically relevant to HIV popula-
tions, or sufficiently characterize interventions and key
HIV outcomes.
Evaluating the relevance of systematic reviews prior to
updating is essential in all fields but particularly import-
ant where there is rapid development of new innovations
and care strategies, as seen in HIV research. Where
there are delays, protocols should be re-evaluated and
adapted to ensure that final reviews answer current
questions. With the recent drive to automate and create
“living” systematic reviews with frequent updates [5, 6],
it is essential that methods of maintaining currency are
incorporated into these evidence synthesis approaches as
questions may change or become irrelevant [7, 8].
We recommend that authors planning to conduct HIV
systematic reviews reflect on how their review can con-
tribute, by thoroughly exploring the current evidence,
determining if primary studies exist on the topic of
interest, identifying other systematic reviews already
conducted, and clearly defining their research question
and what their review may add. In addition to presenting
the PICO (population, intervention, comparison, and
outcomes) elements, authors should fully characterize
the interventions of interest, limit the number and types
of interventions, and determine how to synthesize re-
sults from studies with behavioral or complex interven-
tions. Several available tools can be drawn on and
adapted to aid the design of conceptual frameworks and
characterization of interventions and complexity: this can
help structure review questions to produce meaningful re-
sults [7–11]. Review team effort and Cochrane editorial
procedures need to ensure timely completion of reviews
to avoid them being outdated before completion.
In summary, HIV research questions and the system-
atic reviews summarizing the relevant research evidence
become outdated quickly, and rapid conduct and publi-
cation is critical; clearly defined research questions need
to be regularly re-evaluated alongside changes in the
field to maintain relevance, particularly in the era of liv-
ing systematic reviews.
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